Year: 2025
Type: article
Abstract: Oncology real-world data (RWD) from electronic health records (EHRs) can generate real-world evidence crucial for clinical and policy decisions. However, challenges in accessing and harmonising data across countries limit its global applicability. Flatiron Health has developed oncology EHR-derived RWD datasets in the UK, Germany, and Japan, integrating these with its United States database to support multinational studies. This paper outlines the methods, aligned with the ISPOR EHR-derived data SUITABILITY checklist, to ensure the trustworthiness, reliability, and relevance of these datasets.
Authors: B. Adamson, E. Horne, C. Xu, A. Samani, C. Buhl, P. Mpofu, H. Pittell, Q. Zhang, D. Ng, K. Seidl-Rathkopf, N. Schinwald, E. Tajima, A. Sujenthiran
Institution: Flatiron Health (United States)
Language: English
Subfield: Health Information Management
Field: Health Professions
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,170
Funder: Flatiron Health
OpenAlex ID: W4407238044
